300+ investors in your industry, stage, and region Get
Any industry
Big Data
Video Games
Clean Energy
Google
Construction
Hospitality
EdTech
Consumer
Artificial Intelligence
Local
Enterprise Software
Platforms
Travel
InsurTech
Oil and Gas
Retail
Social Impact
Cryptocurrency
Film
Payments
Photography
Email
CleanTech
Energy
Marketplace
SaaS
Restaurants
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Education
Wellness
Medical Device
Mobile
Sports
Legal
Automotive
eSports
Biotechnology
Software
Renewable Energy
Theatre
Crowdfunding
Recruiting
Web3
Medical
Infrastructure
Beauty
Fashion
Venture Capital
Social
LGBT
Cannabis
Climate
Celebrity
Wine and Spirits
Food and Beverage
Publishing
Life Science
Mobile Apps
Music
Real Estate
Sporting Goods
Art
Digital Media
FinTech
Manufacturing
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Biotech
Sustainability
Transportation
Proptech
Impact
Hardware
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
United Kingdom
Hong Kong
Thailand
United Arab Emirates
Greece
Benin
Croatia
Japan
South Korea
Burkina Faso
Africa
Brazil
Singapore
Oceania
LATAM
Gibraltar
Egypt
Kyrgyzstan
Zambia
Zimbabwe
Sweden
Taiwan
Norway
Tajikistan
Tunisia
Liberia
Malawi
Mexico
Russian Federation
Nigeria
Togo
Nepal
Guinea
Haiti
Iran
Isle of Man
Lesotho
Madagascar
Pakistan
Romania
Oman
Puerto Rico
Poland
Sudan
Guernsey
Cameroon
Andorra
Colombia
China
Armenia
Costa Rica
Kenya
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Morocco
Botswana
Moldova
Seychelles
Paraguay
Canada
South Africa
France
Georgia
Denmark
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
Senegal
El Salvador
Tanzania
India
Germany
Ireland
United States
Indonesia
Middle East
Bermuda
Dominican Republic
Asia
Albania
Qatar
Spain
Angola
Europe
Cyprus
Argentina
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Bulgaria
Ecuador
Estonia
Faroe Islands
Jersey
Bahrain
Bahamas
Bolivia
Belize
Algeria
Italy
Finland
Belarus
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 50 Biotech Startup Investors in Australia (September 2026)

The most active venture capital funds and angel investors investing in Australia Biotech startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in Australia Biotech startup companies. Find investors to raise a Seed, Series A or Series B round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
Uniseed
VC Fund
28 Australia, United States, United Kingdom Series A, Seed, Series B Biotechnology, Manufacturing, Health Care $471k–$22M
Brandon Capital
VC Fund
22 Australia, United Kingdom, United States Series A, Venture - Series Unknown, Seed Biotechnology, Health Care, Medical $673k–$81M
Uniseed Ventures
VC Fund
18 Australia, United States, United Kingdom Series A, Seed, Series B Biotechnology, Health Care, Manufacturing $381k–$94M
Artesian VC
VC Fund
16 Australia, United States, Hong Kong Seed, Series A, Pre-Seed Software, Artificial Intelligence, Health Care $50k–$15M
Medical Research Commercialisation Fund (MRCF)
VC Fund
14 Australia, United States, United Kingdom Series A, Seed, Venture - Series Unknown Biotechnology, Health Care, Medical $1.3M–$35M
Main Sequence Ventures
VC Fund
11 Australia, United States, Philippines Seed, Series A, Series B Software, Artificial Intelligence, Manufacturing $1M–$72M
Stoic VC
VC Fund
8 Australia, United States, United Kingdom Seed, Venture - Series Unknown, Series A Biotechnology, Medical, Health Care $600k–$24M
Melbourne Angels
VC Fund
8 Australia, New Zealand, United States Seed, Angel Software, Information Technology, Biotechnology $34k–$1.5M
Flying Fox Ventures
VC Fund
6 Australia, New Zealand, United States Seed, Series A, Pre-Seed Software, Artificial Intelligence, Information Technology $120k–$11M
Brisbane Angels
VC Fund
6 Australia, New Zealand, United States Seed, Venture - Series Unknown, Pre-Seed Software, Information Technology, Health Care $120k–$2.1M
Horizons Ventures
VC Fund
6 United States, United Kingdom, Canada Series A, Series B, Seed Biotechnology, Software, Artificial Intelligence $1M–$110M
Sydney Angels
VC Fund
5 Australia, United States Seed, Angel, Pre-Seed Software, SaaS, E-Commerce $120k–$1.5M
Australian Medical Angels
VC Fund
5 Australia, Singapore, Hong Kong Seed, Pre-Seed, Series A Health Care, Medical, Software $7.4k–$3.5M
Development Bank of Wales
VC Fund
4 United Kingdom, Australia, United States Seed, Debt Financing, Venture - Series Unknown Software, Health Care, Manufacturing $19k–$5.4M
Possible Ventures
VC Fund
4 Germany, United States, Australia Seed, Pre-Seed, Series A Software, Information Technology, Biotechnology $586k–$47M
Clean Energy Finance Corporation
VC Fund
4 Australia, United Kingdom, United States Debt Financing, Series B, Post-IPO Debt Energy, Renewable Energy, Real Estate $3.9M–$719M
Breakthrough Victoria
VC Fund
4 Australia, United States, Philippines Seed, Venture - Series Unknown, Series A Health Care, Manufacturing, Biotechnology $500k–$35M
OneVentures
VC Fund
4 Australia, United States, Israel Series A, Debt Financing, Venture - Series Unknown Software, Health Care, SaaS $1.2M–$35M
IP Group Australia
VC Fund
4 Australia, New Zealand Seed, Series A, Pre-Seed Biotechnology, Manufacturing, Renewable Energy $811k–$30M
Yuuwa Capital
VC Fund
4 Australia, France Series A, Seed, Series B Medical, Health Care, Biotechnology $131k–$6.4M
QIC BioVentures
VC Fund
3 Australia Series A Medical, Health Care, Biotechnology
Starfish Ventures
VC Fund
3 Australia, United States, Philippines Series A, Series B Software, Enterprise Software, Internet $2M–$18M
GBS Ventures
VC Fund
3 United States, Australia, United Kingdom Series B, Series A Biotechnology, Health Care, Medical Device $2.2M–$35M
Tin Alley Ventures
VC Fund
3 Australia, Philippines, United States Pre-Seed, Seed, Series B Biotechnology, Medical, Software $430k–$20M
Grok Ventures
VC Fund
3 Australia, United States, Singapore Series A, Seed, Series B Renewable Energy, Energy, Software $941k–$151M
South Australian Venture Capital Fund
VC Fund
3 Australia Seed, Series B, Series A Health Care, Biotechnology, Internet of Things $1M–$26M
Radar Ventures
VC Fund
3 Australia, United States, New Zealand Seed, Series A, Venture - Series Unknown Biotechnology, Robotics, Health Care $1.8M–$30M
Queensland Investment Corporation
VC Fund
3 Australia, United States Seed, Series A, Private Equity Software, Information Technology, SaaS $757k–$450M
Tenacious Ventures
VC Fund
3 Australia, United States, New Zealand Seed, Pre-Seed, Series A Agriculture, AgTech, Biotechnology $896k–$49M
Vectr
VC Fund
3 United States, Hong Kong, Singapore Seed, Series A, Series B FinTech, Financial Services, Artificial Intelligence $547k–$70M
Canaan Partners
VC Fund
2 United States, United Kingdom, Israel Series A, Series B, Series C Software, Biotechnology, Health Care $5M–$75M
Mike Wallas
Angel
2 Australia Seed, Series A Video, Water, Biotechnology
Time Ventures
VC Fund
2 United States, Canada, Germany Series A, Series B, Seed Software, Information Technology, Artificial Intelligence $3.1M–$450M
Intermediate Capital Group
VC Fund
2 United Kingdom, France, United States Private Equity, Series B, Secondary Market Biotechnology, Health Care, Information Technology $49M–$439M
Lowercarbon Capital
VC Fund
2 United States, United Kingdom, France Seed, Series A, Series B Renewable Energy, Energy, Biotechnology $3M–$150M
Thistledown Foundation
VC Fund
2 Canada, Germany, Australia Series A, Venture - Series Unknown, Seed Energy, Environmental Engineering, Laser $30M–$40M
Empath Ventures
VC Fund
2 United States, United Kingdom, Canada Seed, Pre-Seed, Convertible Note Health Care, Biotechnology, Personal Health $1.6M–$12M
Tenmile
VC Fund
2 Australia, United States, Canada Venture - Series Unknown, Series A, Seed Health Care, Biotechnology, Manufacturing $2.5M–$177M
BridgeLane Capital
VC Fund
2 Australia, Germany, United States Seed, Series A, Series B Software, E-Commerce, Real Estate $673k–$15M
Investible
VC Fund
2 Australia, United States, Singapore Seed, Series A, Pre-Seed Software, Information Technology, Artificial Intelligence $300k–$20M
Folklore Ventures
VC Fund
2 Australia, United States, New Zealand Seed, Series A Software, Information Technology, Apps $698k–$18M
Hitachi Ventures
VC Fund
2 United States, Australia, United Kingdom Series A, Series B, Series C Software, Artificial Intelligence, Information Technology $10M–$200M
Closed Loop Partners
VC Fund
2 United States, United Kingdom, Canada Seed, Series A, Debt Financing Recycling, Manufacturing, Waste Management $2M–$16M
Regal Funds Management
VC Fund
2 Australia, United States, United Kingdom Convertible Note, Series B, Venture - Series Unknown Software, FinTech, Financial Services $1.9M–$100M
ALIAVIA Ventures
VC Fund
2 Australia, United States Seed, Pre-Seed, Series A Artificial Intelligence, Health Care, Information Technology $200k–$5.6M
Hostplus
VC Fund
2 Australia, United Kingdom, United States Series A, Series B, Series C Software, Biotechnology, Semiconductor $6.3M–$111M
Global Health Investment Fund (GHIF)
VC Fund
2 United States, India, Austria Series B, Series C, Venture - Series Unknown Health Care, Biotechnology, Medical Device $3.5M–$25M
Allan Moss
Angel
2 Australia, United States, The Netherlands Venture - Series Unknown, Series A, Seed Health Care, Medical Device, Biotechnology $2.3M–$25M
UniSA Ventures
VC Fund
2 Australia Seed, Pre-Seed Software, Health Care, Biotechnology
CP Ventures
VC Fund
2 Australia, United States, India Seed, Pre-Seed, Series A Software, Artificial Intelligence, Machine Learning $150k–$12M
Access all 413 investors in Australia Biotech startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

Uniseed
VC Fund · Brisbane, Queensland, Australia · 28 investments in Australia Biotech startups, 7 in the past 12 months

Uniseed is Australia's first, and longest running, university owned venture fund. Established in 2000, we are owned by 9 universities plus CSIRO (behind over 60% of Australia's research) and fund deep-tech spinouts through to global scale.

Show more...

Investment focus

  • Industry: Biotechnology, Manufacturing, Health Care
  • Stage:Series A, Seed, Series B
  • Geography: Australia, United States, United Kingdom

Investor stats

  • Total investments: 91
  • Round size: Seed $670k–$3.5M; Series A $1.6M–$16M; Series B $471k–$22M
  • Lead/follow: 22% lead, 78% follow
  • Last fund: May invest from a new fund soon — raised $15M in 2017

Portfolio highlights

  • DeteQt — Semiconductor chip-based quantum magnetic field sensors using diamond - navigation, mining, medical imaging
  • Plasmaleap — Plasmaleap is a plasma technology company that manufactures and sells zero-emissions chemical reactors designed for industrial and energy applications. The company develops reactor systems that use plasma processes to enable chemical production and transformation without relying on conventional combustion methods. Its technology supports sectorssuch as clean fuels, chemical manufacturing, and materials processing by offering electrified reactor solutions that can be integrated into existing industrial workflows. Plasmaleap designs modular systems that allow operators to deploy plasma reactors for on-site production and conversion of feedstocks using electricity as the primary energy input. The company also provides engineering support and technical integration services to help customers incorporate its reactor technology into commercial operations. Through its plasma-based approach, Plasmaleap focuses on enabling chemical processes that align with decarbonization and emissions reduction objectives across multiple industries.
  • Facet Amtech — Facet Amtech develops and produces ammonia from water and air.
Show all investments...

Brandon Capital
VC Fund · Melbourne, Victoria, Australia · 22 investments in Australia Biotech startups

Brandon Capital invests in the most promising biomedical opportunities that have the potential to improve the lives of patients.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Venture - Series Unknown, Seed
  • Geography: Australia, United Kingdom, United States

Investor stats

  • Total investments: 84
  • Round size: Seed $673k–$9.7M; Series A $5.2M–$81M; Venture - Series Unknown $5.2M–$24M
  • Lead/follow: 35% lead, 65% follow
  • Last fund: Likely actively investing — fresh fund, raised $290M in 2025

Portfolio highlights

  • Ena Respiratory — Ena Respiratory is a biotechnology company seeking to transform the treatment and prevention of respiratory infections and the effectiveness of vaccines.Ena Respiratory novel, synthetic Toll-like receptor 2 (TLR2) receptor agonists have been shown to activate the innate immune system in the respiratory tract and prevent viral and bacterialdissemination to the lungs.
  • Lumonus — Hello, we are Lumonus! We empower oncology care teams through software solutions and services.
  • OncoRes Medical — OncoRes Medical develops an imaging technology to provide intraoperative information available to surgeons to assist with the identification of tumor and healthy tissue.OncoRes Medical is an early-stage medical device company located in Perth, Western Australia and is developing the patent-protected technology in collaboration with leadingresearchers at the University of Western Australia and the Harry Perkins Institute of Medical Research and breast cancer surgeons at the Western Australian public health system.With funding provided by the Medical Research Commercialisation Fund (MRCF), OncoRes Medical aims to develop the technology for use in clinical applications that require the real-time assessment of tissue microstructure.
Show all investments...

Uniseed Ventures
VC Fund · Brisbane, Queensland, Australia · 18 investments in Australia Biotech startups

Uniseed is Australia's first, and longest running, university owned venture fund. Established in 2000, we are owned by 9 universities plus CSIRO (behind over 60% of Australia's research) and fund deep-tech spinouts through to global scale.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Manufacturing
  • Stage:Series A, Seed, Series B
  • Geography: Australia, United States, United Kingdom

Investor stats

  • Total investments: 57
  • Round size: Seed $381k–$4.6M; Series A $1.3M–$16M; Series B $404k–$94M
  • Lead/follow: 12% lead, 88% follow
  • Last fund: May invest from a new fund soon — raised $14M in 2017

Portfolio highlights

  • BioScout — Welcome to BioScout, your partner in revolutionizing the agriculture industry with cutting-edge automated disease detection technology for crop growers and viticulture.
  • Ferronova — Ferronova is a medical device company that offers imaging and surgery products.
  • Morse Micro — Morse Micro's Wi-Fi HaLow combines long-range, strong signal penetration, low power, and high throughput in one wireless protocol, delivering connectivity to more devices, at distance, with greater reliability.
Show all investments...

Artesian VC
VC Fund · Melbourne, Victoria, Australia · 16 investments in Australia Biotech startups

Artesian Capital Management is an alternative investments management company, which was spun out of ANZ Banking Group's capital markets business in 2004, with backing from ANZ Private Equity. Artesian's founding partners, purchased ANZ's stake in 2005. The company has subsequently been fully owned by partners and staff. Since 2004,Artesian has managed specialised funds focused on credit arbitrage and relative-value strategies across global financial markets. In 2008, while continuing to manage credit relative value investment strategies from its New York, London and Singapore offices, Artesian began to make principal investments in seed/early-stage ventures from its offices in Sydney, Melbourne and Shanghai. In 2011, Artesian launched the first of its early stage venture capital funds and now manages AUD +255m. Artesian's VC strategy is to partner with best of breed accelerators, incubators, angel groups and university programs. In 2017, Artesian launched its China VC Fund with a USD 50m cornerstone investment industry super fund Hostplus. Artesian will soon launch a Southeast Asia VC Fund.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Health Care
  • Stage:Seed, Series A, Pre-Seed
  • Geography: Australia, United States, Hong Kong

Investor stats

  • Total investments: 633
  • Round size: Seed $50k–$4.2M; Pre-Seed $70k–$553k; Series A $2.3M–$15M
  • Lead/follow: 36% lead, 64% follow
  • Last fund: Likely still investing — raised $36M in 2023

Portfolio highlights

  • CUZIN — CUZIN is your global shopping family. A community marketplace enabling members to purchase any product worldwide by leveraging other members’ buying access or advantages.Members post requests for any product they want from anywhere in the world. Online or offline, specialist boutiques/clearance outlets and sales. This request is pushed to'cuzins' best placed (geographically or commercially) to purchase the item on their behalf. Cuzins earn a tip for helping out!In addition to accepting a shopping request, any cuzin can instantly monetise being in the right place at the right time posting a purchase opportunity, which is pushed to interested members worldwide. Shopping, shipping, social. Sorted. CUZIN provides the social and logistics platform to facilitate the matching, communication, payment and shipping of the items we love worldwide.
  • Vaulta — Vaulta is a battery casing technology company based in Brisbane, Australia. Using advanced composite materials and smart, streamlined design, Vaulta has developed a lighter and smaller battery case with fewer parts, creating scalable efficiencies and opportunities for manufacturers. Vaulta founder and director Dominic Spooner has over 12 yearsexperience as a design engineer, and has worked in a range of industries, including renewables and batteries, defence and aerospace, consumer products, commercial products and startups. While working in battery design, Dominic saw firsthand that opportunities for growth were being overlooked in favour of continuing with the status quo – and that’s when the idea for Vaulta was born.Vaulta’s world-first no-weld design means modules can be easily assembled and disassembled, cells reused and recycled, and new cells added as battery technology continues to evolve.From stationary storage and electric vehicles to defence, aerospace and beyond, Vaulta’s battery case technology works wherever batteries do.
  • Andromeda Robotics — At Andromeda, our personalised robot companions are helping Australian aged care teams bring joy and connection to residents to improve wellbeing.
Show all investments...

Medical Research Commercialisation Fund (MRCF)
VC Fund · Melbourne, Victoria, Australia · 14 investments in Australia Biotech startups

Medical Research Commercialisation Fund (MRCF) provides dedicated, investment funding to support the commercialisation of early-stage medical research discoveries that originate from its member institutes. The collaborative nature of the MRCF seeks to foster best practice in the commercialisation of medical innovations.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Seed, Venture - Series Unknown
  • Geography: Australia, United States, United Kingdom

Investor stats

  • Total investments: 33
  • Round size: Seed $1.3M–$1.7M; Series A $1.3M–$13M; Venture - Series Unknown $4.3M–$35M
  • Lead/follow: 45% lead, 55% follow

Portfolio highlights

  • MycRx — MecRx is a drug development company that works on new treatments for cancer and novel mechanism of action antibiotics. Using proprietary “hit identification” technology, MecRx is developing inhibitors of cMyc, a protein that is deregulated in over 50% of all human cancers. MecRx draws on the expertise of the Peter MacCallum Cancer Centre and CSIROand is headquartered in Melbourne, Australia.MecRx was founded in 2013 by an ex-pharma/biotech team. MecRx is run as a virtual company based in Melbourne, Australia and its shareholders and service providers include the Peter MacCallum Cancer Institute and CSIRO. The company secured $5m Series A investment from the MRCF (www.mrcf.com.au) and CSIRO in 2015.
  • Currus Biologics — Currus Biologics develops BEAT technology to advance CAR T-cell therapy for solid tumors, aiming to improve treatment outcomes in oncology.
  • Azura Ophthalmics — Azura Ophthalmics is a clinical-stage company that develops an innovative portfolio of compounds to advance treatments for MGD, the leading cause of DED. By targeting the root cause of MGD, Azura brings the promise of improved health and well-being to millions of people worldwide who suffer from MGD and other ocular surface diseases where treatmentoptions are currently lacking. Azura is underpinned by an experienced management team with an established track record of successfully developing and commercializing novel treatments for ocular surface diseases. The company headquartered in Tel Aviv-Yafo, Israel with operations in Australia and the U.S.
Show all investments...

Main Sequence Ventures
VC Fund · Sydney, New South Wales, Australia · 11 investments in Australia Biotech startups

We work with inventors who are building something hard from their unique expertise in science. These inventors are building the industries that will thrive for the decades to come. We have a unique working model to accelerate a company's pathway to scale.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Manufacturing
  • Stage:Seed, Series A, Series B
  • Geography: Australia, United States, Philippines

Investor stats

  • Total investments: 135
  • Round size: Seed $1M–$7M; Series A $4.8M–$30M; Series B $14M–$72M
  • Lead/follow: 41% lead, 59% follow
  • Last fund: Likely still investing — raised $305M in 2023

Portfolio highlights

  • Diraq — Diraq is building quantum computers using modified silicon transistors, the technology best suited to reaching utility scale, where value outweighs cost.
  • Andromeda Robotics — At Andromeda, our personalised robot companions are helping Australian aged care teams bring joy and connection to residents to improve wellbeing.
  • Gilmour Space Technologies — Gilmour Space is a rocket company in Australia that is developing and launching low-cost small satellite launch vehicles. All orbits, all planets: https://www.gspacetech.com
Show all investments...

Stoic VC
VC Fund · Sydney, New South Wales, Australia · 8 investments in Australia Biotech startups

Stoic VC is an early-stage venture fund backing founders at the forefront of University Innovation. We partner with Uniseed to accelerate the commercialisation of university research across the ANZ.

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Health Care
  • Stage:Seed, Venture - Series Unknown, Series A
  • Geography: Australia, United States, United Kingdom

Investor stats

  • Total investments: 25
  • Round size: Seed $600k–$4.6M; Series A $8.3M–$16M; Venture - Series Unknown $2.2M–$24M
  • Lead/follow: 4% lead, 96% follow
  • Last fund: May invest from a new fund soon — raised $11M in 2017

Portfolio highlights

  • Ena Respiratory — Ena Respiratory is a biotechnology company seeking to transform the treatment and prevention of respiratory infections and the effectiveness of vaccines.Ena Respiratory novel, synthetic Toll-like receptor 2 (TLR2) receptor agonists have been shown to activate the innate immune system in the respiratory tract and prevent viral and bacterialdissemination to the lungs.
  • Lenexa Medical — Lenexa Medical is an Australian based MedTech company.
  • Kinoxis Therapeutics — Developing novel therapeutics for social dysfunction and substance use disorders.
Show all investments...

Melbourne Angels
VC Fund · Melbourne, Victoria, Australia · 8 investments in Australia Biotech startups

Melbourne Angels is the most active startup investor in Victoria, one of the most active in Australia. Investing in start-ups since 2007, Melbourne Angels is committed to helping innovative founders build the next generation of our economy.

Show more...

Investment focus

  • Industry: Software, Information Technology, Biotechnology
  • Stage:Seed, Angel
  • Geography: Australia, New Zealand, United States

Investor stats

  • Total investments: 70
  • Round size: Seed $34k–$1.5M; Angel $200k–$918k
  • Lead/follow: 36% lead, 64% follow

Portfolio highlights

  • Emanda — Thinking about selling your business in Australia? Emanda guides you through every step: business valuation, health check, corporate compliance, and sale process. Start with a business valuation.
  • Auric Essentials — Auric - The Power of Scent. Revolutionise your well-being with Auric. Discover our state-of-the-art AI-powered AromaSphere diffuser and app, designed to personalise your aromatherapy experience.
  • Bitwise Agronomy — Bitwise Agronomy uses AI to analyze crop video footage and provide growers with insights into crop health, growth, and yield potential.
Show all investments...

Flying Fox Ventures
VC Fund · Melbourne, Victoria, Australia · 6 investments in Australia Biotech startups

Flying Fox Ventures is an early stage investment firm that invests across industry and across the micro-stages of pre-seed and seed.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Information Technology
  • Stage:Seed, Series A, Pre-Seed
  • Geography: Australia, New Zealand, United States

Investor stats

  • Total investments: 112
  • Round size: Seed $662k–$3.2M; Pre-Seed $120k–$3M; Series A $649k–$11M
  • Lead/follow: 6% lead, 94% follow

Portfolio highlights

  • Operata — Continuously measure performance to deliver the best possible customer experience.
  • SPEC Toolbox — Structural timber design software for Australian engineers. Design CLT, GLT, and connections to AS1720 standards. Start your free trial and automate today.
  • Teacher’s Buddy — Create lesson plans, worksheets, assessments, and more in minutes. AI-powered tools designed for educators.
Show all investments...

Brisbane Angels
VC Fund · Brisbane, Queensland, Australia · 6 investments in Australia Biotech startups

Formed in late 2006, the Brisbane Angels Pty Ltd is a large group of private investors who actively invest in early stage technology companies, usually in South East Queensland, Australia. The members are typically active or semi-retired former senior business executives, who apart from financial input can provide much needed value adding toinvestee companies through hands-on management experience and high level business networks.

Show more...

Investment focus

  • Industry: Software, Information Technology, Health Care
  • Stage:Seed, Venture - Series Unknown, Pre-Seed
  • Geography: Australia, New Zealand, United States

Investor stats

  • Total investments: 107
  • Round size: Seed $120k–$2.1M; Pre-Seed $200k–$1.4M
  • Lead/follow: 8% lead, 92% follow

Portfolio highlights

  • Giftbee — Giftbee reshapes gifting for businesses and consumers. Send gifts with flexibility to accept, swap, or give forward. Manage gifting programs, reduce waste, and create meaningful impact.
  • Indi — Connect the village around your child and track what matters. Organise records, therapy goals and your care team in one place.
  • Ovum — Meet Ovum, the intelligent health journal mobile app designed for womankind.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Horizons Ventures
VC Fund · Hong Kong, Hong Kong Island, Hong Kong · 6 investments in Australia Biotech startups

Investing in the deep science and technology that can propel humanity towards a radically better future.

Show more...

Investment focus

  • Industry: Biotechnology, Software, Artificial Intelligence
  • Stage:Series A, Series B, Seed
  • Geography: United States, United Kingdom, Canada

Investor stats

  • Total investments: 330
  • Round size: Seed $1M–$10M; Series A $6M–$47M; Series B $10M–$110M
  • Lead/follow: 42% lead, 58% follow

Portfolio highlights

  • Magisto — Magisto online video editor is a fast & powerful video maker. Turn your photos and video clips into video stories with Magisto movie editor. Start free!
  • Jobspotting — Jobspotting is a recommendations engine that suggests relevant jobs to users based on their skills and experience. The engine is powered by Skills Graph and Semantic Analysis technology. The company was founded in 2013 in Berlin, Germany by ex-Googlers Hessam Lavi, Jan Backes and Manuel Holtz. Robin Haak joined the founding team in 2014 aftermeeting them through the Axel Springer Plug and Play Accelerator Programme, of which he was a co-founder. Jobspotting successfully acquired seed funding.
  • Atomo Coffee — Atomo Coffee is a developer of molecular coffee. Atomo has reverse-engineered the coffee bean to create a smooth cup of coffee, made of naturally derived ingredients, and more sustainable than current commercial coffee.
Show all investments...

Sydney Angels
VC Fund · Sydney, New South Wales, Australia · 5 investments in Australia Biotech startups

Sydney Angels is a not-for-profit angel investment membership organisation. Since our establishment in 2008, they have stayed true to our mission of supporting the early-stage ecosystem by running processes and events that connect our investing members with promising early-stage companiesThey believe that encouraging smart investment in startupcompanies will benefit both our members’ portfolios and Australia’s emergent innovation economy.They see this as the ultimate win-win situation. Sydney Angels is led by an elected committee of ten volunteers who meet weekly. It is supported by an operations manager and alliance partners.

Show more...

Investment focus

  • Industry: Software, SaaS, E-Commerce
  • Stage:Seed, Angel, Pre-Seed
  • Geography: Australia, United States

Investor stats

  • Total investments: 99
  • Round size: Seed $120k–$1.5M; Angel $130k–$1.1M; Pre-Seed $337k–$1.5M
  • Lead/follow: 35% lead, 65% follow
  • Last fund: May invest from a new fund soon — last raise in 2016

Portfolio highlights

  • Keeyu — keeyu. is a B2B SaaS platform that continuously monitors e-commerce transactions from payment to delivery. Should any issue emerge, our system immediately notifies the customer service team, enabling proactive issue resolution before it impacts the customer, saving them from opening a support ticket. The result is an enhanced post-purchaseexperience, ensuring sales retention and reducing customer complaints.Founded in 2023, the company is headquartered in Sydney, Australia, and is dedicated to empowering businesses to deliver exceptional post-purchase experiences.
  • iiShield — iiShield aims to improve patient outcomes and surgeon training in transplant surgery by providing effective organ heat protection.
  • Mary Technology — Generate detailed chronologies from documents in minutes with Mary Technology. Achieve 90%+ time reduction and ensure 99%+ accuracy. Try for free.
Show all investments...

Australian Medical Angels
VC Fund · 5 investments in Australia Biotech startups

Medical Angels is the premier medical and health-specific angel investment syndicate, comprised of over 1,000 clinicians from across Australia. In 2026, we

Show more...

Investment focus

  • Industry: Health Care, Medical, Software
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Australia, Singapore, Hong Kong

Investor stats

  • Total investments: 22
  • Round size: Seed $7.4k–$1.7M; Pre-Seed $550k–$1M; Series A $3.3M–$3.5M
  • Lead/follow: 9% lead, 91% follow

Portfolio highlights

  • GXE — At GXE, our mission is to build the all-in-one platform for unlisted assets and funds management. We provide investors, fund managers, and family offices with the tools they need to succeed and enable them to focus on their portfolios and investors whilst GXE takes care of everything else. A licensed financial services company, GXE holdsAustralian Financial Services Licence 460870 issued by the Australian Securities and Investments Commission. GXE welcomes clients across sectors including corporate, family offices, pension and superannuation fund managers, private equity, property, and venture capital.
  • Graphics et al. — Graphics et al. is a software that offers to create graphic designs. Graphics et al. mission is to make scientific communication easier.
  • Clean Slate Clinic — We are a for-purpose healthcare company focused on helping Australians keen to detox from alcohol, safely from home.
Show all investments...

Development Bank of Wales
VC Fund · Cardiff, Cardiff, United Kingdom · 4 investments in Australia Biotech startups

Development Bank of Wales is an independent company, providing commercial funding to Welsh SMEs. They invests private and public funds, including EU funds.

Show more...

Investment focus

  • Industry: Software, Health Care, Manufacturing
  • Stage:Seed, Debt Financing, Venture - Series Unknown
  • Geography: United Kingdom, Australia, United States

Investor stats

  • Total investments: 288
  • Round size: Seed $327k–$3M; Debt Financing $19k–$3.7M; Venture - Series Unknown $350k–$5.4M
  • Lead/follow: 62% lead, 38% follow
  • Last fund: May invest from a new fund soon — raised $27M in 2018

Portfolio highlights

  • nisien.ai — Nisien.ai uses industry-leading AI for the detection, defence and resolution of online harm, for better online safety and digital wellbeing.
  • Design and Supply — Design and Supply are specialist manufacturers and suppliers of Industrial Steel Doors and Architectural Products.
  • Outlook Expeditions — Ready. For Life.
Show all investments...

Possible Ventures
VC Fund · Munich, Bayern, Germany · 4 investments in Australia Biotech startups, 8 in the past 12 months

Possible Ventures backs ambitious teams building frontier technology to positively impact society. We invest globally in the early stages, actively supporting founders via our collective of global entrepreneurs.

Show more...

Investment focus

  • Industry: Software, Information Technology, Biotechnology
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Germany, United States, Australia

Investor stats

  • Total investments: 172
  • Round size: Seed $1.5M–$10M; Pre-Seed $586k–$3.5M; Series A $9.7M–$47M
  • Lead/follow: 5% lead, 95% follow

Portfolio highlights

  • Mkind — Mkind builds intelligent robots for high-mix manufacturing, developing advanced automation solutions that can adapt to diverse production requirements, improve operational efficiency, and support manufacturers in handling complex, low-volume, and frequently changing product lines.
  • Orbem — Transform biological imaging with AI-powered MRI technology. Non-invasive solutions for poultry, fruits, nuts, and health. Building a sustainable future.
  • Transition Metal Solutions — Transition harnesses wild microbial communities to recover copper and other critical metals from low-grade mining resources.
Show all investments...

Clean Energy Finance Corporation
VC Fund · Sydney, New South Wales, Australia · 4 investments in Australia Biotech startups

The Clean Energy Finance Corporation invests using a commercial approach to overcome market barriers and mobilize investment in renewable energy, energy efficiency, and low emissions technologies. They seek to catalyze and leverage private sector funding for the commercialization and deployment of clean energy technologies necessary for thetransition to a carbon-constrained economy.

Show more...

Investment focus

  • Industry: Energy, Renewable Energy, Real Estate
  • Stage:Debt Financing, Series B, Post-IPO Debt
  • Geography: Australia, United Kingdom, United States

Investor stats

  • Total investments: 151
  • Round size: Series B $3.9M–$77M; Post-IPO Debt $41M–$719M; Debt Financing $21M–$329M
  • Lead/follow: 43% lead, 57% follow
  • Last fund: May invest from a new fund soon — raised $72M in 2018

Portfolio highlights

  • Zenobe Energy — Zenobe Energy ( formerly known as Battery Energy Storage Solutions Limited) is the largest independent owner and operator of battery storage in the UK. We transform the way grid operators and businesses use power to reduce costs, improve reliability and benefit the environment.
  • Renewable Metals — Renewable Metals' unique alkali recycling process recovers critical minerals from old batteries so they can be used again and again.
  • Agile Energy — Empowering Australian businesses with solar, power purchase agreement, batteries, carbon offsets & renewable energy. Save costs, cut emissions, and start your sustainability journey today!
Show all investments...

Breakthrough Victoria
VC Fund · Melbourne, Victoria, Australia · 4 investments in Australia Biotech startups

The Breakthrough Victoria Fund is a $2 billion investment by the Victorian Government to drive investment in research and innovation.

Show more...

Investment focus

  • Industry: Health Care, Manufacturing, Biotechnology
  • Stage:Seed, Venture - Series Unknown, Series A
  • Geography: Australia, United States, Philippines

Investor stats

  • Total investments: 55
  • Round size: Seed $708k–$6.8M; Series A $4M–$35M; Venture - Series Unknown $500k–$30M
  • Lead/follow: 53% lead, 47% follow

Portfolio highlights

  • AlleSense — AlleSense has developed a unique and novel solution to label-free imaging, the NanoMslide.
  • Mental Jam — We are a games studio dedicated to ​creating impactful experiences that ​explore mental health.
  • Deftbiotech — Deftbiotech is a biotech startup developing peptide-based antifungal treatments for nail and skin infections.
Show all investments...

OneVentures
VC Fund · Sydney, New South Wales, Australia · 4 investments in Australia Biotech startups

OneVentures is a later-stage venture capital firm focused on scaling Technology and Healthcare companies through growth equity and credit. The firm's role extends far beyond investment, as the firm actively guides companies toward achieving their next critical milestones. By leveraging decades of global experience and operational expertise,OneVentures accelerates growth and helps shape the future of its portfolio companies.A global growth focus drives their investment selection, with their current portfolio including companies with truly innovative products tackling multi-billion-dollar problems, from needle-free vaccinations to virtual communications to adaptive e-learning.

Show more...

Investment focus

  • Industry: Software, Health Care, SaaS
  • Stage:Series A, Debt Financing, Venture - Series Unknown
  • Geography: Australia, United States, Israel

Investor stats

  • Total investments: 87
  • Round size: Series A $1.5M–$23M; Debt Financing $1.2M–$14M; Venture - Series Unknown $3M–$35M
  • Lead/follow: 44% lead, 56% follow
  • Last fund: Likely actively investing — fresh fund, raised $126M in 2025

Portfolio highlights

  • me&u — me&u is an online ordering and payment application designed to order meals. They provide communication technology to order and pay through mobile phones at restaurants. Their process of ordering with waiters and splitting bills that enable users to order their food and pay bills through a digital payment platform.
  • Truescope — Make better informed communications decisions with Truescope. Harnessing millions of media posts every day to deliver you real-time information that influences your business strategy.
  • Vertero — Axial Therapeutics is a biotechnology company fundamentally changing the treatment of neurological diseases and disorders by harnessing groundbreaking science in the microbiome-gut-brain axis.
Show all investments...

IP Group Australia
VC Fund · Surry Hills, New South Wales, Australia · 4 investments in Australia Biotech startups

Ip Group Australia build and support outstanding intellectual property-based companies.

Show more...

Investment focus

  • Industry: Biotechnology, Manufacturing, Renewable Energy
  • Stage:Seed, Series A, Pre-Seed
  • Geography: Australia, New Zealand

Investor stats

  • Total investments: 15
  • Round size: Seed $1.3M–$2.3M; Pre-Seed $811k–$896k; Series A $3M–$30M
  • Lead/follow: 47% lead, 53% follow

Portfolio highlights

  • ElectraLith — The cleanest, most versatile and most cost-efficient method of extracting and refining lithium, the primary element of a sustainable future.
  • MGA Thermal — MGA Thermal, specialists in thermal energy storage technology. Renewable, high-power, economical, modular, safe and sustainable thermal storage solutions.
  • Atisama Therapeutics — Atisama Therapeutics is an Australian biotech company pioneering splice-switching oligonucleotide (SSO) therapies that restore normal gene transcription pathways to treat disease at the molecular level.
Show all investments...

Yuuwa Capital
VC Fund · Perth, Western Australia, Australia · 4 investments in Australia Biotech startups

Yuuwa Capital is a $40M early-stage venture capital firm based in Perth, Western Australia. They are actively seeking outstanding investment opportunities where Yuuwa can provide both capital and expertise to help founders, management and early investors to turn good ideas into great companies.

Show more...

Investment focus

  • Industry: Medical, Health Care, Biotechnology
  • Stage:Series A, Seed, Series B
  • Geography: Australia, France

Investor stats

  • Total investments: 18
  • Round size: Seed $131k–$808k; Series A $979k–$4.2M; Series B $2.6M–$6.4M
  • Lead/follow: 56% lead, 44% follow
  • Last fund: May invest from a new fund soon — raised $37M in 2009

Portfolio highlights

  • Nexgen Plants — Healthy plants, healthy people, living planet. Nexgen develop's plants for future generations that will improve the environment and health of future generations.
  • Icetana — icetana Motion Intelligence dramatically improves the active monitoring of security surveillance networks, with AI video anomaly detection and video analytics.
  • Agworld — Plan your crop, mitigate your risks, improve your profitability with Agworld farm management software.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
QIC BioVentures
VC Fund · Brisbane, Queensland, Australia · 3 investments in Australia Biotech startups

QIC BioVentures, previously known as Queensland BioCapital Funds, was established by the Queensland Investment Corporation (QIC) in October 2002 as its venture capital arm specialising in biotechnology. Like any other QIC Fund, QBF's purpose is to maximize investment returns for QIC's clients. QBF does not provide grants or other formsof assistance.

Show more...

Investment focus

  • Industry: Medical, Health Care, Biotechnology
  • Stage:Series A
  • Geography: Australia

Investor stats

  • Total investments: 3
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Verva Pharmaceuticals — Verva Pharmaceuticals Ltd. (“Verva”) was formed in December, 2007 by consolidation of key diabetes assets, discovery technologies and targets resident in Autogen Research Ltd. (formerly the diabetes-focused subsidiary of ChemGenex Pharmaceuticals) with those of obesity drug development company Adipogen Pharmaceuticals Pty Ltd. The combined productportfolio, technologies and expertise provide a substantial opportunity for rapid clinical progress and growth in high-value markets with a significant unmet medical need.Verva operates in a completely virtual mode, managed by a CEO and Directors with extensive international product development and partnering experience. Verva’s founding research was undertaken at the Metabolic Research Unit of Deakin University in Geelong, Australia; a state-of-the-art facility providing access to key in vitro and in vivo models and capabilities. Verva has subsequently engaged expert scientists, clinicians, technical advisers and contract research organisations worldwide to implement the Company’s research and development strategy.
  • Protagonist Therapeutics — Protagonist Therapeutics is a clinical-stage biopharmaceutical company with a proprietary technology platform focused on discovering and developing peptide-based new chemical entities (NCEs) that can potentially transform existing treatment paradigms in disease areas with significant unmet medical needs.
Show all investments...

Starfish Ventures
VC Fund · Melbourne, Victoria, Australia · 3 investments in Australia Biotech startups

Starfish Ventures is an Australian venture capital firm focused on information technology, life sciences, and clean technology companies.

Show more...

Investment focus

  • Industry: Software, Enterprise Software, Internet
  • Stage:Series A, Series B
  • Geography: Australia, United States, Philippines

Investor stats

  • Total investments: 59
  • Round size: Series A $2M–$6.6M; Series B $2.5M–$18M
  • Lead/follow: 47% lead, 53% follow
  • Last fund: May invest from a new fund soon — raised $162M in 2008

Portfolio highlights

  • CAP-XX — CAP-XX makes ultra-thin, high-power supercapacitors for portable and compact devices. Ideal for energy storage. Quotes & samples available.
  • Ourcast — Ourcast Inc. has a mobile app that it says can accurately predict precipitation during the next two hours.
  • Smart Urban Properties Australia (SUPA) — Smart Urban Properties Australia (SUPA) offers a unique range of property solutions by bringing together renewable energy and mobility, super-speed fiber, and smart prop-tech. It is formed by bringing together Epsilon Security, b.energy, Fibrecorp, Smart Automation Systems, and connecX.
Show all investments...

GBS Ventures
VC Fund · Melbourne, Victoria, Australia · 3 investments in Australia Biotech startups

Founded in 1996, GBS invests in young businesses developing and commercialising products which, when combined with the right management and finance, will make a significant difference to patients' lives and deliver financial returns for their investors. Their areas of particular interest and expertise include human healthcare, biotechnologyproduct development and life science start-ups. In particular, recent investments have included biological or small molecule therapeutics, medical devices and diagnostics.GBS invests in private or public companies whether at start-up or later stages of company development. Their investors include major Australian superannuation funds.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical Device
  • Stage:Series B, Series A
  • Geography: United States, Australia, United Kingdom

Investor stats

  • Total investments: 41
  • Round size: Series A $2.2M–$9M; Series B $9.1M–$35M
  • Lead/follow: 22% lead, 78% follow
  • Last fund: May invest from a new fund soon — raised $86M in 2009

Portfolio highlights

  • Ivantis — Ivantis, Inc. is a company focused on developing an innovative treatment for Glaucoma. It is their goal to develop a less invasive, more effective option for the 60+ million people worldwide suffering from Primary Open Angle Glaucoma. As they successfully address this initial goal, it is then there intention to focus on innovative development forthe treatment of other debilitating diseases within ophthalmology.
  • Moximed — Moximed Inc. is dedicated to improving the standard of care for patients with osteoarthritis, and is investigating therapies to treat a number of affected joints. The lead product, the KineSpring® Knee Implant System, is designed for patients with knee osteoarthritis.
  • Elastagen — Elastagen is a clinical stage medical company with an advanced pipeline of products based on the human protein tropoelastin, a pioneering medical biomaterial. Elastin is a critical component of tissues in the human body which require the ability to stretch and recoil, such as the skin, lungs, arteries, elastic ligaments. Elastagen hasdeveloped a synthetic version of the elastin protein which is identical to that naturally present in the human body. Elastagen’s platform technology has potential applications in a number of areas including skin rejuvenation, scar remodelling and tissue repair. Elastagen was founded following the acquisition of intellectual property rights to the elastin technology which was developed by Prof Weiss at the University of Sydney. The Company has since successfully attracted capital from a number of leading Australian and overseas life science venture capital groups. Elastagen’s operations have expanded from its Australian base to include production in Europe and clinical operations in the UK.
Show all investments...

Tin Alley Ventures
VC Fund · Carlton, Victoria, Australia · 3 investments in Australia Biotech startups

Tin Alley Ventures collaborates with companies and researchers in the University of Melbourne's ecosystem to invest in & support world-changing businesses.

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Software
  • Stage:Pre-Seed, Seed, Series B
  • Geography: Australia, Philippines, United States

Investor stats

  • Total investments: 8
  • Round size: Seed $2.9M–$20M; Pre-Seed $430k–$2.9M
  • Lead/follow: 13% lead, 87% follow

Portfolio highlights

  • Mirugen — Mirugen is a preclinical biotechnology company (re)programming cells to unlock innate cellular repair mechanisms.
  • Twin1 AI — Twin1 is a privacy-first platform that gives every professional an AI-powered digital twin to scale their expertise.
  • Kronus — Full-stack development infrastructure for safety-critical systems.
Show all investments...

Grok Ventures
VC Fund · Surry Hills, New South Wales, Australia · 3 investments in Australia Biotech startups

Backing a better tomorrow

Show more...

Investment focus

  • Industry: Renewable Energy, Energy, Software
  • Stage:Series A, Seed, Series B
  • Geography: Australia, United States, Singapore

Investor stats

  • Total investments: 70
  • Round size: Seed $941k–$10M; Series A $3.5M–$63M; Series B $26M–$151M
  • Lead/follow: 26% lead, 74% follow

Portfolio highlights

  • Endolith — Endolith is a biotech company transforming sustainable mining by leveraging microbes, synthetic biology, and cloud computing to extract more critical minerals like copper from low-grade ores. Working with the many of the leading mining companies, Endolith is advancing its innovative technology to commercial scale. Recognized as a finalist in theBHP Unearthed BioMetals cohort and a member of the Alaska Critical Minerals Collaborative, Endolith is driving the future of mining with sustainable, efficient, and responsible solutions for the clean energy transition.
  • MAKO — Solving human problems with nature’s surfaces.
  • Asterix Foods — Asterix Foods is a biotechnology company designed to build protein production using plant-cell culture techniques. The company's platform is developing and growing bioactive proteins for food that are scalable, functional, and complex, enabling users with plant cell-cultured and animal-free proteins.It was founded in 2022 and is located inTel Aviv, Israel.
Show all investments...

South Australian Venture Capital Fund
VC Fund · Adelaide, South Australia, Australia · 3 investments in Australia Biotech startups

South Australian Venture Capital Fund - helping build dynamic and innovative South Australian startups / scaleups and accelerate their growth to a national and global scale.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Internet of Things
  • Stage:Seed, Series B, Series A
  • Geography: Australia

Investor stats

  • Total investments: 14
  • Round size: Seed $1M–$12M; Series A $2.3M–$20M; Series B $13M–$26M
  • Lead/follow: 14% lead, 86% follow

Portfolio highlights

  • Ferronova — Ferronova is a medical device company that offers imaging and surgery products.
  • Seonix Bio — Seonix Bio is dedicated to helping health professionals, individuals and researchers understand glaucoma risk using genetics.
  • Pearler.AI — Pearler gives your team super powers to respond fast to RFP, RFI, RFQ, Security, Cyber, Risk & Grant Questionnaires.
Show all investments...

Radar Ventures
VC Fund · 3 investments in Australia Biotech startups

Radar Ventures operates as an venture capital firm.

Show more...

Investment focus

  • Industry: Biotechnology, Robotics, Health Care
  • Stage:Seed, Series A, Venture - Series Unknown
  • Geography: Australia, United States, New Zealand

Investor stats

  • Total investments: 22
  • Round size: Seed $1.8M–$11M; Series A $3.2M–$15M; Venture - Series Unknown $19M–$30M
  • Lead/follow: 5% lead, 95% follow

Portfolio highlights

  • Acumino — Acumino offers next-generation, AI powered robot models for the execution of highly dexterous tasks in industrial automation settings. The Acumino AI is trained on the most accurate data of robot interactions and facilitates the deployment of next-generation intelligent robot workers in a fast, scalable, reliable, cost-efficient manner, unlockingunmatched dexterity & ROI.
  • OncoRes Medical — OncoRes Medical develops an imaging technology to provide intraoperative information available to surgeons to assist with the identification of tumor and healthy tissue.OncoRes Medical is an early-stage medical device company located in Perth, Western Australia and is developing the patent-protected technology in collaboration with leadingresearchers at the University of Western Australia and the Harry Perkins Institute of Medical Research and breast cancer surgeons at the Western Australian public health system.With funding provided by the Medical Research Commercialisation Fund (MRCF), OncoRes Medical aims to develop the technology for use in clinical applications that require the real-time assessment of tissue microstructure.
  • Diag-Nose.io — Antibiotic resistance is rising to dangerously high levels in all parts of the world threatening our ability to treat common infectious diseases. Diag-Nose is working on a novel diagnostic tool to non-invasively distinguish between viral,bacterial and allergy-mediated sinusitis.
Show all investments...

Queensland Investment Corporation
VC Fund · Brisbane, Queensland, Australia · 3 investments in Australia Biotech startups

Queensland Investment Corporation is an investment company.

Show more...

Investment focus

  • Industry: Software, Information Technology, SaaS
  • Stage:Seed, Series A, Private Equity
  • Geography: Australia, United States

Investor stats

  • Total investments: 29
  • Round size: Seed $757k–$10M; Series A $3.6M–$10M; Private Equity $239M–$450M
  • Lead/follow: 45% lead, 55% follow
  • Last fund: Likely still investing — raised $15M in 2022

Portfolio highlights

  • ModnPods — B2B modular manufacturing for multi-storey & hybrid developments across QLD & NSW. Backed by McNab. Accelerate builds by 50%.
  • Pacific Energy — Our innovative energy solutions are transforming the way power is generated, delivered, and managed across the nation.
  • Gilmour Space Technologies — Gilmour Space is a rocket company in Australia that is developing and launching low-cost small satellite launch vehicles. All orbits, all planets: https://www.gspacetech.com
Show all investments...

Tenacious Ventures
VC Fund · Melbourne, Victoria, Australia · 3 investments in Australia Biotech startups

Tenacious Ventures - Australia's first and only dedicated agrifood tech VC firm.

Show more...

Investment focus

  • Industry: Agriculture, AgTech, Biotechnology
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Australia, United States, New Zealand

Investor stats

  • Total investments: 24
  • Round size: Seed $1.1M–$10M; Pre-Seed $896k–$2.2M; Series A $5.9M–$49M
  • Lead/follow: 50% lead, 50% follow
  • Last fund: Likely still investing — fund raised in 2022

Portfolio highlights

  • Nbryo — Contact Us for interest: contact@nbryo.com
  • Agovor — Agovor - Robotic towing machines to boost productivity while reducing your environmental footprint.
  • SwarmFarm Robotics — Global crop protection specialists ADAMA and Australian ag-tech company.
Show all investments...

Vectr
VC Fund · Sheung Wan, Hong Kong Island, Hong Kong · 3 investments in Australia Biotech startups

Vectr is a venture firm based in Hong Kong. They combine investment, creation and growth to deliver game-changing impact to teams ready to tackle global issues, transform industries and improve the lives of millions.That combines capital, creation and partnership to deliver game-changing impact. We strive to be the ideal partner for founders thatare building transformation products and looking to expand their businesses into asia.

Show more...

Investment focus

  • Industry: FinTech, Financial Services, Artificial Intelligence
  • Stage:Seed, Series A, Series B
  • Geography: United States, Hong Kong, Singapore

Investor stats

  • Total investments: 81
  • Round size: Seed $547k–$6.5M; Series A $1M–$37M; Series B $12M–$70M
  • Lead/follow: 21% lead, 79% follow

Portfolio highlights

  • Percent — Unlock private credit investments with Percent. Access alternative investments on the platform powering the future of private markets.
  • Micro Connect — Micro Connect provides market infrastructure, fintech, and platform development.
  • MasterExchange — Trading platform for music rights leveraging emerging technology to create friction free and compliant investment opportunities to everyone.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Canaan Partners
VC Fund · Menlo Park, California, United States · 2 investments in Australia Biotech startups

Canaan is an early stage venture capital firm that invests in entrepreneurs with visionary ideas. With $5B under management, a diversified fund and over 190 exits to date, Canaan has invested in some of the world's leading technology and healthcare companies over the past 30 years. Canaan’s focus areas include fintech, enterprise/cloud,marketplaces, frontier tech, biopharma, digital health, and medtech.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Health Care
  • Stage:Series A, Series B, Series C
  • Geography: United States, United Kingdom, Israel

Investor stats

  • Total investments: 673
  • Round size: Series A $5M–$42M; Series B $8M–$75M; Series C $7.1M–$55M
  • Lead/follow: 32% lead, 68% follow
  • Last fund: Likely still investing — raised $100M in 2024

Portfolio highlights

  • withco — withco is a provider of real estate and technology services for small businesses. withco was founded in 2019 and is based in Brooklyn, NY, USA.
  • Berkshire Grey — Berkshire Grey develops a materials handling system intended to automate omnichannel fulfillment. Its system utilizes artificial intelligence, computer vision, machine learning, and novel sensing to deploy intelligent robotic systems that automate tasks never before performed by machines in commercial settings, enabling customers to achieve higheraccuracy and throughput speeds than traditional approaches as well as handle the broadest assortment of products, packaging, and parcels with ease.
  • GroundWork — GroundWork delivers Unified Monitoring for Real™ with an open software platform for shockingly easy integrations and customized visualizations of cloud, virtualization, network, application, server, and storage data.GroundWork Monitor is available in free (Core) and subscription versions with support (Enterprise).GroundWork was founded in 2004 andis headquartered in San Francisco, California with partners in Asia Pacific, Europe and South America.
Show all investments...

Mike Wallas
Angel · Brisbane, Queensland, Australia · 2 investments in Australia Biotech startups

Mike Wallas - Advisory Board @ Optifire Pty Ltd

Show more...

Investment focus

  • Industry: Video, Water, Biotechnology
  • Stage:Seed, Series A
  • Geography: Australia

Investor stats

  • Total investments: 3
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • PERKii — PERKii Targeted Release Probiotics are naturally micro-shielded to resist stomach acid up to 10,000x stronger than non micro-shield probiotics. For a targeted release in your gut and a difference you can feel. PERKii Probiotic Drinks are bottled with one billion or more probiotics per serve.
  • Clipchamp — Create videos with royalty-free music and stock footage, use video templates, and export in up to 4K video resolution. Get started in-browser or download the Windows app.
Show all investments...

Time Ventures
VC Fund · California, Kentucky, United States · 2 investments in Australia Biotech startups

Time Ventures is an investment fund for Marc Benioff. The company looks to invest in theB2B, hospitality, non-financial services, and commercial products and services sectors.

Show more...

Investment focus

  • Industry: Software, Information Technology, Artificial Intelligence
  • Stage:Series A, Series B, Seed
  • Geography: United States, Canada, Germany

Investor stats

  • Total investments: 57
  • Round size: Seed $3.1M–$450M; Series A $10M–$80M; Series B $20M–$140M
  • Lead/follow: 7% lead, 93% follow

Portfolio highlights

  • Laurel — Time by Ping frees lawyers from timekeeping so they can focus on their work, and firms can understand where time is being spent.
  • June.ai — Discover June, a digital communication hub that replaces your email experience. June creates a new world for your existing email that gives you more control, interactivity and efficiency.
  • June — Transform enterprise system deployment with June. AI-driven implementation for Salesforce, Snowflake, SAP & more. No downtime, faster delivery, full control.
Show all investments...

Intermediate Capital Group
VC Fund · London, England, United Kingdom · 2 investments in Australia Biotech startups

We are a global alternative asset manager creating sustainable value by partnering with ambitious businesses

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Information Technology
  • Stage:Private Equity, Series B, Secondary Market
  • Geography: United Kingdom, France, United States

Investor stats

  • Total investments: 43
  • Round size: Series B $50M–$172M; Private Equity $49M–$439M
  • Lead/follow: 72% lead, 28% follow
  • Last fund: Likely actively investing — fund raised in 2025

Portfolio highlights

  • FUNECAP GROUPE — FUNECAP GROUPE provides activities and national services of funeral parlors, crematoriums, coffins, marble works, funerary articles, funeralROC ECLERC remains true to its policy: the guarantee of the best quality of services and products at prices accessible to all. The brand carries strong values ​​of respect for families, irreproachable qualityand the search for the right price. They represent a constant commitment to families.
  • Mediar Therapeutics — Mediar Therapeutics is a preclinical stage biotechnology company developing antibody-based therapeutics to halt fibrosis in a variety of organ systems, including lung, liver, kidney, and skin.
  • Excellera Advisory Group — Excellera Advisory Group is an Italian consultancy specializing in government affairs and reputation management.
Show all investments...

Lowercarbon Capital
VC Fund · New York, New York, United States · 2 investments in Australia Biotech startups

Lowercarbon Capital backs kickass companies slashing CO2 emissions, sucking carbon out of the sky, and buying us time to unf**k the planet.

Show more...

Investment focus

  • Industry: Renewable Energy, Energy, Biotechnology
  • Stage:Seed, Series A, Series B
  • Geography: United States, United Kingdom, France

Investor stats

  • Total investments: 225
  • Round size: Seed $3M–$12M; Series A $11M–$50M; Series B $21M–$150M
  • Lead/follow: 40% lead, 60% follow
  • Last fund: Likely actively investing — fresh fund, raised $11M in 2025

Portfolio highlights

  • Terraton — Terraton is a biochar platform that provides equipment, design, and financing to agribusiness operators.
  • River — Empowering people, improving lives.
  • Antora Energy — Antora converts low-cost, intermittent renewable electricity into a reliable, on-demand source of zero-emissions industrial heat and power.
Show all investments...

Thistledown Foundation
VC Fund · Ottawa, Ontario, Canada · 2 investments in Australia Biotech startups

Thistledown Foundation is a private charitable foundation.

Show more...

Investment focus

  • Industry: Energy, Environmental Engineering, Laser
  • Stage:Series A, Venture - Series Unknown, Seed
  • Geography: Canada, Germany, Australia

Investor stats

  • Total investments: 6
  • Round size: Series A $30M–$40M
  • Lead/follow: 17% lead, 83% follow

Portfolio highlights

  • Avnos — Our HDAC solution offers the broadest geographic potential available, enabling our technology to operate in water-scarce environments.
  • Loam Bio — Loam has designed farmer-focused carbon projects that support farmers to build stable soil carbon in cropping and mixed farming systems.
  • Marvel Fusion — Marvel Fusion is a developer of fusion energy technology used to offer environment-friendly and safe energy. Its reactor is based on the short pulse, high energy, and electrically efficient laser that is suited for commercializing baseload fusion electrical power helping consumers to access clean, safe, and reliable energy sources.The company wasfounded in 2019 and is headquartered in Munich, Bayern.
Show all investments...

Empath Ventures
VC Fund · Los Angeles, California, United States · 2 investments in Australia Biotech startups

Empath Ventures is a venture capital firm that mainly invests in psychedelic medicine companies. The firm specializes in the fields of investment financial services, finance, and venture capital. It was founded in 2021 and headquartered in Los Angeles California.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Personal Health
  • Stage:Seed, Pre-Seed, Convertible Note
  • Geography: United States, United Kingdom, Canada

Investor stats

  • Total investments: 18
  • Round size: Seed $1.6M–$12M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Xylo Bio — Psylo is an Australia-based psychedelic biotech business focusing on Psychedelic-inspired medicine to treat mental illness.
  • Motif Neurotech — We're building DOT, a miniature brain stimulator designed to restore healthy brain activity in patients with treatment-resistant depression.
  • Aperture Therapeutics — Aperture Therapeutics is building an innovative drug discovery platform that embraces the genetic diversity of patients and leverages mechanistic understanding of protective gene variants in the human population.
Show all investments...

Tenmile
VC Fund · Perth, Western Australia, Australia · 2 investments in Australia Biotech startups

Tenmile invest quickly and confidently because it lacks the constraints that most venture capital funds.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Manufacturing
  • Stage:Venture - Series Unknown, Series A, Seed
  • Geography: Australia, United States, Canada

Investor stats

  • Total investments: 21
  • Round size: Seed $2.5M–$8M; Series A $3M–$177M; Venture - Series Unknown $7.5M–$90M
  • Lead/follow: 29% lead, 71% follow

Portfolio highlights

  • Kantoko — Kantoko is a dedicated Australian mental health platform that provides online ADHD assessment, diagnosis, and long-term care for adults.
  • AdvanCell — AdvanCell is a vertically integrated, clinical-stage radiopharmaceutical company developing an innovative pipeline of targeted alpha therapies.
  • Syndeio Biosciences — Syndeio Biosciences is a clinical-stage biotechnology company focused on developing therapies to restore and enhance synaptic health in central nervous system (CNS) disorders.
Show all investments...

BridgeLane Capital
VC Fund · Sydney, New South Wales, Australia · 2 investments in Australia Biotech startups

The BridgeLane Group is a privately-owned asset management firm specialising in the agricultural, real estate and innovation sectors. A significant global player in agriculture with a multi-decade record in large scale farming, the Group has a proud history in residential property development, comme

Show more...

Investment focus

  • Industry: Software, E-Commerce, Real Estate
  • Stage:Seed, Series A, Series B
  • Geography: Australia, Germany, United States

Investor stats

  • Total investments: 20
  • Round size: Seed $673k–$4.6M; Series A $3M–$6.1M; Series B $5M–$15M
  • Lead/follow: 35% lead, 65% follow

Portfolio highlights

  • MadeComfy — Award-winning Airbnb management service in Australia and New Zealand. MadeComfy is a selected official partner of Airbnb. Find out how we earn you higher returns with short-term rentals.
  • Futurerent — With Futurerent, property investors can get up to $100,000 in a seamless, loan-free experience that's so simple, banks can only dream of it.
  • Evrima Technologies — Our clinical trial recruitment and management services put participants first. Trusted, timely clinical trial results are a good thing - for everybody.
Show all investments...

Investible
VC Fund · Sydney, New South Wales, Australia · 2 investments in Australia Biotech startups

Investible is an early-stage venture capital firm backing the visionaries advancing humanity through technology in Australia, New Zealand, Southeast Asia and globally.

Show more...

Investment focus

  • Industry: Software, Information Technology, Artificial Intelligence
  • Stage:Seed, Series A, Pre-Seed
  • Geography: Australia, United States, Singapore

Investor stats

  • Total investments: 244
  • Round size: Seed $300k–$5.1M; Pre-Seed $392k–$2M; Series A $1.7M–$20M
  • Lead/follow: 38% lead, 62% follow
  • Last fund: Likely still investing — fund raised in 2023

Portfolio highlights

  • Apate.AI — Is the next generation of scam prevention and intelligence. We deploy advanced conversational AI bots combined with real-time insights to protect businesses, governments and communities globally.2
  • Inspace XR — Inspire and engage prospective tenants, buyers, and your team with interactive virtual replicas of your assets, with 360 virtual tours, analytics & more.
  • GeoSnapShot — Let's put your photos to work. Built for professionals, available to everyone. GeoSnapShot is loved by amateurs, professionals, teams and individuals.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Folklore Ventures
VC Fund · Sydney, New South Wales, Australia · 2 investments in Australia Biotech startups

Folklore is a team of investors, founders, and builders committed to supporting Australian and New Zealand tech founders. We are a first cheque to forever investment firm, and we believe in the power of founder vision and the potential of teams, right from the start.

Show more...

Investment focus

  • Industry: Software, Information Technology, Apps
  • Stage:Seed, Series A
  • Geography: Australia, United States, New Zealand

Investor stats

  • Total investments: 52
  • Round size: Seed $698k–$5.5M; Series A $1.2M–$18M
  • Lead/follow: 44% lead, 56% follow
  • Last fund: May invest from a new fund soon — raised $70M in 2021

Portfolio highlights

  • Arkeus — Arkeus is a leader in the fusion of optics and autonomy. Our wide area autonomous optical systems are deployed to conduct Search, Intelligence, Surveillance and Reconnaissance in a range of operating environments.
  • Sphere — Live courses led by vetted experts for professionals who want to advance their careers
  • Octopusbot — Empowering agribusinesses with 97% accurate AI forecasts, 7 months ahead of the market to mitigate weather risk and price volatility.
Show all investments...

Hitachi Ventures
VC Fund · München, Bayern, Germany · 2 investments in Australia Biotech startups

Official website of Hitachi, Ltd. Hitachi drives Social Innovation Business, creating a sustainable society with data and technology. We will solve customers' and society's challenges with Lumada solutions leveraging IT, OT (Operational Technology) and products.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Information Technology
  • Stage:Series A, Series B, Series C
  • Geography: United States, Australia, United Kingdom

Investor stats

  • Total investments: 72
  • Round size: Series A $10M–$50M; Series B $21M–$100M; Series C $30M–$200M
  • Lead/follow: 19% lead, 81% follow
  • Last fund: Likely actively investing — fresh fund, raised $400M in 2025

Portfolio highlights

  • Zenity — Zenity empowers enterprises to enable AI Agents securely. Our platform ensures adaptive security and governance from buildtime to runtime.
  • Arcee.ai — Learn how Arcee helps you build your own LLMs in your own cloud.
  • ClearOps — ClearOps is the AI-powered After Sales Platform connecting machinery OEMs, dealers and machines to improve spare parts availability, fill rates and machine uptime.
Show all investments...

Closed Loop Partners
VC Fund · New City, New York, United States · 2 investments in Australia Biotech startups

We Invest in the Circular Economy, a New Economic Model Focused on a Profitable and Sustainable Future.

Show more...

Investment focus

  • Industry: Recycling, Manufacturing, Waste Management
  • Stage:Seed, Series A, Debt Financing
  • Geography: United States, United Kingdom, Canada

Investor stats

  • Total investments: 47
  • Round size: Seed $2M–$7M; Series A $6M–$16M; Debt Financing $2.6M–$10M
  • Lead/follow: 47% lead, 53% follow
  • Last fund: Likely still investing — raised $200M in 2022

Portfolio highlights

  • Supersede — Looking for sustainable lightweight waterproof plywood alternative. Upgrade your marine and construction projects with Supersede eco friendly materials.
  • TemperPack — Science-driven sustainable packaging for cold chain, food, pharma, pet and more. ClimaCell, Green Cell Foam and WaveKraft platforms. ISTA-certified.
  • GreenMantra Technologies — and fuels by recycling plastics utilizes a proprietary thermo-catalytic system and patented process to cost-effectively convert and up-cycle waste plastics, including hard-to-recycle materials such as grocery bags and film, into high-value waxes and other specialty chemicals. These materials have a broad range of applications in the coatings,plastics processing, adhesives, roofing and paving industries.
Show all investments...

Regal Funds Management
VC Fund · Sydney, New South Wales, Australia · 2 investments in Australia Biotech startups

Regal Funds Management was founded in 2004 by Andrew and Philip King. Regal utilises a long/short investment strategy and performs investment management and investment advisory services to a number of Australian Unit Trusts and Cayman Island Companies.

Show more...

Investment focus

  • Industry: Software, FinTech, Financial Services
  • Stage:Convertible Note, Series B, Venture - Series Unknown
  • Geography: Australia, United States, United Kingdom

Investor stats

  • Total investments: 85
  • Round size: Series B $7M–$30M; Convertible Note $1.9M–$18M; Venture - Series Unknown $4.8M–$100M
  • Lead/follow: 33% lead, 67% follow
  • Last fund: Likely still investing — raised $52M in 2022

Portfolio highlights

  • Send Payments — SendFX provides cross-border payment and remittance services to individuals and SMEs.
  • Firmus Technologies — Building the cloud infrastructure of tomorrow, today.
  • Iondrive — Iondrive is an exploration company that provides metals. They offer products that include gold, silver, copper, and other metals. They provide services for industrial use.
Show all investments...

ALIAVIA Ventures
VC Fund · Los Angeles, California, United States · 2 investments in Australia Biotech startups

Investing early in female-founded AI companies across the U.S. and Australia.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Health Care, Information Technology
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Australia, United States

Investor stats

  • Total investments: 15
  • Round size: Seed $750k–$5.6M; Pre-Seed $200k–$1.3M; Series A $649k–$1.7M
  • Lead/follow: 27% lead, 73% follow

Portfolio highlights

  • Human Health — Human aims to assist medical professionals and patients to make more statistics selections.
  • InsightWise — Win more proposals and grants, and drive growth faster than ever.
  • GoFIGR — We are a talent insights and opportunity marketplace platform that helps you develop, engage and retain employees in the flow of work.
Show all investments...

Hostplus
VC Fund · Melbourne, Victoria, Australia · 2 investments in Australia Biotech startups

Join our leading Australian superannuation fund, committed to putting our members first, with a low admin fee and strong returns. Become a member today!

Show more...

Investment focus

  • Industry: Software, Biotechnology, Semiconductor
  • Stage:Series A, Series B, Series C
  • Geography: Australia, United Kingdom, United States

Investor stats

  • Total investments: 63
  • Round size: Series A $6.3M–$49M; Series B $20M–$111M; Series C $13M–$60M
  • Lead/follow: 16% lead, 84% follow

Portfolio highlights

  • Emesent — Solutions for GPS-denied environments - delivering revolutionary efficiency, safety and operational insights to underground mining and other industries.
  • Gradiant — Gradiant is a solutions provider and developer of cleantech water projects for advanced water and wastewater treatment. They provide microelectronics, pharmaceuticals, food and beverage, lithium and key minerals, and renewable energy.
  • Gilmour Space Technologies — Gilmour Space is a rocket company in Australia that is developing and launching low-cost small satellite launch vehicles. All orbits, all planets: https://www.gspacetech.com
Show all investments...

Global Health Investment Fund (GHIF)
VC Fund · New York, New York, United States · 2 investments in Australia Biotech startups

The Global Health Investment Fund (GHIF) is a $108 million social impact investment fund designed to provide financing to advance the development of drugs, vaccines, diagnostics and other interventions against diseases that disproportionately burden low- and middle-income countries. GHIF supports late-stage innovations for public health challengessuch as malaria, pre-eclampsia, cholera, HIV and river blindness, with an emphasis on infectious diseases and maternal/infant health issues that cause significant morbidity and mortality in resource-limited settings. GHIF may also make investments that improve or expand access to existing products—such as developing pediatric formulations of approved therapeutics or improving the stability of widely-used global health vaccines.As an investment fund with a limited time-horizon, GHIF seeks opportunities that have a high probability of successful commercialization within two or three years. Products with “dual market” potential are of greatest interest; i.e., those that will have a clear impact on public health in developing countries but also have value in high-income countries. High-volume / low-margin products, such as essential vaccines, are also of significant interest.GHIF employs a range of investment structures including mezzanine debt, convertible debt, preferred equity and project financing with an average investment target of approximately $10 million per project. Each GHIF project must advance the Fund’s social impact objectives and demonstrate the ability to achieve commercial success.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical Device
  • Stage:Series B, Series C, Venture - Series Unknown
  • Geography: United States, India, Austria

Investor stats

  • Total investments: 21
  • Round size: Series B $7.5M–$19M; Series C $4.5M–$14M; Venture - Series Unknown $3.5M–$25M
  • Lead/follow: 43% lead, 57% follow
  • Last fund: May invest from a new fund soon — raised $108M in 2012

Portfolio highlights

  • Monod Bio — Monod Bio l Simple. Powerful. Biosensors for Medicine & Biotech.
  • CXL Ophthalmics — CXLO is developing a minimally invasive treatment for an ectatic corneal disease that can bring early intervention to millions of patients globally.
  • Endpoint Health — Endpoint Health is a precision-first therapeutics company. By rewriting the molecule-first drug development model, we aim to deliver precision therapies that have the potential to improve outcomes for patients with immune-driven illnesses.
Show all investments...

Allan Moss
Angel · Sydney, New South Wales, Australia · 2 investments in Australia Biotech startups

Allan Moss acts an adviser to Anchorage’s Investment Committee. Currently Principal of Allan Moss Investments, a private investment company, Allan retired from the role of Managing Director and Chief Executive Officer of Macquarie Group in May 2008. He was with Macquarie Group for 31 years and served as CEO from 1993 to his retirement in2008. He was also a non- executive director of CSR Ltd from 1996 to 2001.Allan graduated from Sydney University in Arts with a major in Economics and in Laws with Honours. He is also a graduate of Harvard University with a Masters Degree in Business Administration with High Distinction. Allan has received numerous industry awards and recognitions. He was twice named by Barron’s Magazine as one of the 30 most respected CEOs in the world (2006, 2007). He was appointed an Officer of the Order of Australia in 2005.

Show more...

Investment focus

  • Industry: Health Care, Medical Device, Biotechnology
  • Stage:Venture - Series Unknown, Series A, Seed
  • Geography: Australia, United States, The Netherlands

Investor stats

  • Total investments: 9
  • Round size: Series A $2.3M–$8.8M; Venture - Series Unknown $3.5M–$25M
  • Lead/follow: 11% lead, 89% follow

Portfolio highlights

  • Skykraft — Skykraft is an Australian space services firm that specializes in smallsat constellation design, production, and operation.
  • Ferronova — Ferronova is a medical device company that offers imaging and surgery products.
  • Invert Robotics — From inspection to insight. We build the Physical AI layer for industrial asset integrity. Get repeatable, decision-ready data and asset life analytics - without confined space entry
Show all investments...

UniSA Ventures
VC Fund · Adelaide, South Australia, Australia · 2 investments in Australia Biotech startups

UniSA Ventures is the technology commercialisation and investment management company of the University of South Australia (UniSA).

Show more...

Investment focus

  • Industry: Software, Health Care, Biotechnology
  • Stage:Seed, Pre-Seed
  • Geography: Australia

Investor stats

  • Total investments: 3
  • Lead/follow: 33% lead, 67% follow
  • Last fund: May invest from a new fund soon — raised $31M in 2019

Portfolio highlights

  • Ferronova — Ferronova is a medical device company that offers imaging and surgery products.
  • Framework — Framework is an all-in-one tool for teams and individuals. You can use Framework to do anything from project management, sales pipeline & customer relationship management, wiki & documentation, team communication (team chat, voice & video calls), and meeting scheduling.Framework can help organize your ideas with nodes. A node is apiece of information and each node is connected and related to other nodes.
Show all investments...

CP Ventures
VC Fund · Sydney, New South Wales, Australia · 2 investments in Australia Biotech startups

CP Ventures is a boutique, high-performance global venture capital firm backing breakthrough 4th Industrial Revolution technologies.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Machine Learning
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Australia, United States, India

Investor stats

  • Total investments: 91
  • Round size: Seed $482k–$4.2M; Pre-Seed $150k–$900k; Series A $3.8M–$12M
  • Lead/follow: 42% lead, 58% follow

Portfolio highlights

  • LeadStory — Watch breaking news from around the world and stay up to date with current events. Follow topics that matter to you from providers you can trust. See whats happening nearby or in places you care about.
  • Greenfly — Greenfly's short-form media orchestration software platform captures, collects, organizes & distributes videos & photos to drive fan engagement and boost revenue for sports and entertainment organizations.
  • Skylark Labs — Skylark Labs develops continuously evolving and customizable threat detection systems for enhanced physical security. Our clients (CCTV or Drone companies) can customize our proprietary AI solutions at the time of deployment or continuously evolve them if needed after deployment making them preferable to other comparable market solutions.
Show all investments...

Biotech Investor funding in Australia at a glance

Stats across 458 deals from 413 investors.

413
investors
in Australia Biotech startups
458
deals
in Australia Biotech startups
$3.1M
median round
in Australia Biotech startups
51%
lead investors
lead at least one round
26%
Grant
most common funding stage
92/8
VC / Angel
share of investor count

Access all 413 investors in Australia Biotech startups.

Open List

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Biotech Investors in Australia investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 413 investors investing in Australia Biotech startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists